Complete Response Letters: US FDA Tells Congress Broader Disclosures To Sponsors Could Be ‘Chilling’

 
• By Derrick Gingery
  
Rep. Neal Dunn, R-FL, questions CBER Director Peter Marks
Rep. Neal Dunn, R-Fla., questions CBER Director Peter Marks during a House Energy and Commerce Health Subcommittee hearing on the new FDA user fee agreements. • Source: Screenshot

More from User Fees

More from Pathways & Standards